Karanjin as a Neuroprotective Agent: Mitigating Amyloid Beta‐Induced Toxicity in Alzheimer's Disease Models.
This study underscores the therapeutic potential of karanjin in mitigating amyloid beta-induced cellular toxicity. At 1 μM, karanjin exhibited significant improvements in cell viability, oxidative stress reduction, and mitochondrial function, making it a promising candidate for targeting key mechanisms in neurodegenerative diseases like Alzheimer's.
Authors
- Veer Bala Gupta (ORCID: https://orcid.org/0000-0003-4989-0764)
- Kunal Dhiman (ORCID: https://orcid.org/0000-0001-6462-7281)
- Manas Chakraborty
Institutions
- Deakin University (AU)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_102464
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00